**Advances in the Treatment of Renal Cell Carcinoma**

Editors

**Grant D Stewart Paul Reynolds**

MDPI • Basel • Beijing • Wuhan • Barcelona • Belgrade • Manchester • Tokyo • Cluj • Tianjin

*Editors* Grant D Stewart Department of Surgery University of Cambridge Cambridge United Kingdom Paul Reynolds Medicine St Andrews St Andrews United Kingdom

*Editorial Office* MDPI St. Alban-Anlage 66 4052 Basel, Switzerland

This is a reprint of articles from the Special Issue published online in the open access journal *Cancers* (ISSN 2072-6694) (available at: www.mdpi.com/journal/cancers/special issues/RCC cancer).

For citation purposes, cite each article independently as indicated on the article page online and as indicated below:

LastName, A.A.; LastName, B.B.; LastName, C.C. Article Title. *Journal Name* **Year**, *Volume Number*, Page Range.

**ISBN 978-3-0365-2935-6 (Hbk) ISBN 978-3-0365-2934-9 (PDF)**

© 2022 by the authors. Articles in this book are Open Access and distributed under the Creative Commons Attribution (CC BY) license, which allows users to download, copy and build upon published articles, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications.

The book as a whole is distributed by MDPI under the terms and conditions of the Creative Commons license CC BY-NC-ND.

## **Contents**


Reprinted from: *Cancers* **2020**, *12*, 1673, doi:10.3390/cancers12061673 . . . . . . . . . . . . . . . . **163**

## **Magdalena Rudzi ´nska, Alessandro Parodi, Valentina D. Maslova, Yuri M. Efremov, Neonila V. Gorokhovets and Vladimir A. Makarov et al.**

Cysteine Cathepsins Inhibition Affects Their Expression and Human Renal Cancer Cell Phenotype

Reprinted from: *Cancers* **2020**, *12*, 1310, doi:10.3390/cancers12051310 . . . . . . . . . . . . . . . . **177**

#### **Trace M. Jones, Jennifer S. Carew and Steffan T. Nawrocki**

Therapeutic Targeting of Autophagy for Renal Cell Carcinoma Therapy Reprinted from: *Cancers* **2020**, *12*, 1185, doi:10.3390/cancers12051185 . . . . . . . . . . . . . . . . **197**
